214 related articles for article (PubMed ID: 23290394)
1. [Monoclonal antibodies targeting IL-17A or its receptor in psoriasis: a new therapeutic approach?].
Bonnet MC; Bagot M; Bensussan A
Med Sci (Paris); 2012 Dec; 28(12):1035-7. PubMed ID: 23290394
[No Abstract] [Full Text] [Related]
2. Use of brodalumab for the treatment of psoriasis and psoriatic arthritis.
Kivelevitch DN; Menter A
Immunotherapy; 2015; 7(4):323-33. PubMed ID: 25917624
[TBL] [Abstract][Full Text] [Related]
3. Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application.
Ariza ME; Williams MV; Wong HK
Clin Immunol; 2013 Feb; 146(2):131-9. PubMed ID: 23314273
[TBL] [Abstract][Full Text] [Related]
4. The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis.
AbuHilal M; Walsh S; Shear N
J Cutan Med Surg; 2016 Nov; 20(6):509-516. PubMed ID: 27207350
[TBL] [Abstract][Full Text] [Related]
5. Targeting interleukin-17 receptors.
Lee WH; Wu HH; Huang CK
Oncotarget; 2015 Jul; 6(21):18244-5. PubMed ID: 26285835
[No Abstract] [Full Text] [Related]
6. Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly.
Mylle S; Grine L; Speeckaert R; Lambert JLW; van Geel N
Am J Clin Dermatol; 2018 Oct; 19(5):625-637. PubMed ID: 30003497
[TBL] [Abstract][Full Text] [Related]
7. IL-17 for therapy.
Kurschus FC; Moos S
J Dermatol Sci; 2017 Sep; 87(3):221-227. PubMed ID: 28633806
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
Mudigonda P; Mudigonda T; Feneran AN; Alamdari HS; Sandoval L; Feldman SR
Dermatol Online J; 2012 Oct; 18(10):1. PubMed ID: 23122008
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 17-A inhibition in the treatment of psoriasis.
Yiu ZZ; Griffiths CE
Expert Rev Clin Immunol; 2016; 12(1):1-4. PubMed ID: 26561053
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis: from Pathogenesis to Targeted Therapies.
Conrad C; Gilliet M
Clin Rev Allergy Immunol; 2018 Feb; 54(1):102-113. PubMed ID: 29349534
[TBL] [Abstract][Full Text] [Related]
11. Ixekizumab for treatment of psoriasis.
Dyring-Andersen B; Skov L; Zachariae C
Expert Rev Clin Immunol; 2015 Apr; 11(4):435-42. PubMed ID: 25748485
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatment.
Frleta M; Siebert S; McInnes IB
Curr Rheumatol Rep; 2014 Apr; 16(4):414. PubMed ID: 24570394
[TBL] [Abstract][Full Text] [Related]
13. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A.
Rizzo HL; Kagami S; Phillips KG; Kurtz SE; Jacques SL; Blauvelt A
J Immunol; 2011 Feb; 186(3):1495-502. PubMed ID: 21172868
[TBL] [Abstract][Full Text] [Related]
14. The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond.
Brembilla NC; Senra L; Boehncke WH
Front Immunol; 2018; 9():1682. PubMed ID: 30127781
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapies: what they teach us about the pathogenesis of psoriasis and psoriatic arthritis.
Tan WS; Kelly S; Pitzalis C
Expert Rev Clin Immunol; 2017 Mar; 13(3):207-222. PubMed ID: 27690678
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of emerging immunotherapies in psoriasis.
Yiu ZZ; Warren RB
Immunotherapy; 2015; 7(2):119-33. PubMed ID: 25713988
[TBL] [Abstract][Full Text] [Related]
17. Rationale and early clinical data on IL-17 blockade in psoriasis.
Nwe SM; Champlain AH; Gordon KB
Expert Rev Clin Immunol; 2013 Jul; 9(7):677-82. PubMed ID: 23899238
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis.
Chiricozzi A
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():9-20. PubMed ID: 25398488
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
20. Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?
Chiricozzi A; Saraceno R; Chimenti MS; Guttman-Yassky E; Krueger JG
Expert Opin Ther Targets; 2014 May; 18(5):513-25. PubMed ID: 24568095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
